{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2024-04-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20231013",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "75732",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212099s004lbl.pdf",
              "date": "20231016",
              "type": "Label"
            },
            {
              "id": "75780",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/212099Orig1s004ltr.pdf",
              "date": "20231016",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20220805",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "71739",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/212099Orig1s002ltr.pdf",
              "date": "20220808",
              "type": "Letter"
            },
            {
              "id": "71775",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212099s002lbl.pdf",
              "date": "20220811",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20190730",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "59518",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212099Orig1s000lbl.pdf",
              "date": "20190731",
              "type": "Label"
            },
            {
              "id": "59521",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/212099Orig1s000ltr.pdf",
              "date": "20190731",
              "type": "Letter"
            },
            {
              "id": "59870",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/212099Orig1s000TOC.cfm",
              "date": "20190829",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210107",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "65871",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/212099Orig1s001ltr.pdf",
              "date": "20210108",
              "type": "Letter"
            },
            {
              "id": "65873",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212099s001lbl.pdf",
              "date": "20210108",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA212099",
      "sponsor_name": "BAYER HEALTHCARE",
      "openfda": {
        "application_number": ["NDA212099"],
        "brand_name": ["NUBEQA"],
        "generic_name": ["DAROLUTAMIDE"],
        "manufacturer_name": ["Bayer HealthCare Pharmaceuticals Inc."],
        "product_ndc": ["50419-395"],
        "product_type": ["HUMAN PRESCRIPTION DRUG"],
        "route": ["ORAL"],
        "substance_name": ["DAROLUTAMIDE"],
        "rxcui": ["2180330", "2180336"],
        "spl_id": ["78565601-df32-45a6-9d08-ac84738c8963"],
        "spl_set_id": ["1a7cb212-56e4-4b9d-a73d-bfee7fe4735e"],
        "package_ndc": ["50419-395-01", "50419-395-72"],
        "unii": ["X05U0N2RCO"]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "NUBEQA",
          "active_ingredients": [
            {
              "name": "DAROLUTAMIDE",
              "strength": "300MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}
